AI guidance for stomach and colorectal cancer treatment
Part of Cancer, Digestive system clinical trials.
This study uses a computer program (like ChatGPT) to help doctors recommend the best treatments for people with stomach or colorectal cancer. All your care must happen at one of the study hospitals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have stomach cancer or colorectal cancer confirmed by a biopsy.
- Your medical records are available and complete from before treatment started.
- You will receive all your cancer treatment at a hospital taking part in this study.
- You do not have any other type of cancer.
- You are not getting cancer treatment at more than one hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized AI program can give you better health advice based on your stomach condition. It is for people who have gastric intestinal metaplasia (GIM) or have had H. pylori infection and are already scheduled for a gastroscopy.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study compares treatment recommendations from a computer system with those from a team of cancer doctors. It may help improve how cancer care decisions are made.
This trial tests whether using a blood test for cancer DNA (ctDNA) can help decide if more chemotherapy is needed after surgery and chemo for advanced stomach cancer. It may help tailor treatment to your individual risk of cancer returning.
This trial tests personalized prevention strategies to help lower the risk of stomach (gastric) and colon (colorectal) cancer in community members. It may help by tailoring screening and prevention steps to your individual health and risk factors.
This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.
Hear when a new Gastrointestinal Neoplasm Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.